Magazine Article | April 1, 2021

Insights On How Outsourcing Decisions Are Made

Source: Life Science Leader

By Kate Hammeke, VP of Market Research, Industry Standard Research (ISR) @ISRreports

Every drug innovator has its own way of choosing service providers and its own way of prioritizing their CDMO selection criteria. These criteria often change from project to project and from sponsor to sponsor. At the same time, there are components of the CDMO selection process that are not influenced by the type of molecule, the stage of development, or the company’s main outsourcing driver. Data from Industry Standard Research’s development and commercial outsourcing models offer insight into the decision-making process, as well as details on why sponsors opt for different contracting approaches, from tactical outsourcing to the use of preferred providers and engaging in strategic partnerships.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader